p38-MAPK
Catalog No. | Inhibitor Name | p38 MAPK | p38α | p38β | Other |
---|---|---|---|---|---|
A10824 | SB203580 | * | PKB | ||
A10148 | Doramapimod | **** | |||
A10823 | SB202190 | ** | ** | ||
A10545 | LY2228820 | **** | |||
A10982 | VX-702 | *** | |||
A11078 | PH-797804 | *** | * | ||
A10983 | VX-745 | *** | * | ||
A11582 | TAK-715 | **** | * | ||
A11562 | SB239063 | ** | ** | ||
A12526 | Losmapimod | *** | *** | ||
A11321 | Skepinone-L | **** | |||
A10895 | Pexmetinib | Tie-2 | |||
A10970 | AMG 548 | **** | *** | ||
A11221 | PD 169316 | ** | |||
A11563 | SD-06 | * | |||
A12408 | ML-3043 | * | IL-1β, TNF-α | ||
A12770 | Talmapimod (SCIO-469) | *** | |||
A13551 | Pamapimod (R-1503) | *** | * | ||
A13552 | RWJ 67657 | * | * | ||
A13563 | BMS-582949 | *** | |||
A13678 | SB-242235 | *** | |||
A16015 | AL 8697 | **** | |||
A16035 | SX 011 | *** | |||
A16038 | JX 401 | ** |
Notes:
1.Hover mouse over " " to view the IC50 value.(A few compounds have proven potency but without published IC50 data.)
2.For more details about the compound, click on the product name of your interest.
3.The higher the number of " " is, the more potent the inhibitor or activator is.
4."" refers to compounds which do inhibitory effects on the related isoform, but without specific value.
-
DBM 1285 dihydrochloride
Catalog No. A16058 -
SB 706504
Catalog No. A16055 -
EO 1428
Catalog No. A16037 -
SX 011
Catalog No. A16035 -
AL 8697
Catalog No. A16015 -
SKF 86002 Dihydrochloride
Catalog No. A11101 p38 MAPK 抑制剂SKF 86002 Dihydrochloride是p38 MAP激酶的抑制剂(IC50 = 0.1-1 uM)。有效抑制人单核细胞中LPS诱导的IL-1和TNF-α的产生(IC50 = 1 uM)。 了解更多 -
AMG 548
Catalog No. A10970 -
Pexmetinib (ARRY-614)
Catalog No. A10895 p38 MAPK 抑制剂Pexmetinib (ARRY-614)是通过双重抑制p38促分裂原活化蛋白激酶(MAPK)和Tie2/Tek受体酪氨酸激酶,其在HEK-293细胞中的IC50分别为4 nM/18 nM。Pexmetinib是一种有效的细胞因子合成抑制剂。 了解更多 -
BMS-582949
Catalog No. A13563 -
SB-242235
Catalog No. A13678 -
Doramapimod (BIRB-796)
Catalog No. A10148 p38 MAPK 抑制剂Doramapimod(BIRB 796)是p38 MAPK的小分子抑制剂,在调节促炎细胞因子的产生中起关键作用。 了解更多 -
PH-797804
Catalog No. A11078 -
Skepinone-L
Catalog No. A11321 -
TA-02
Catalog No. A13644 -
FR 167653 free base
Catalog No. A21110 p38 MAPK inhibitorFR 167653 free base, an orally active and selective p38 MAPK inhibitor, is a potent suppressor of TNF-α and IL-1β production via specific inhibition of p38 MAPK activity. 了解更多 -
SB 203580 hydrochloride
Catalog No. A21526 p38 MAPK inhibitorSB 203580 hydrochloride (RWJ 64809 hydrochloride) is a widely used p38 MAPK inhibitor. 了解更多 -
MW-150 hydrochloride
Catalog No. A21854 p38α MAPK inhibitorMW-150 hydrochloride (MW01-18-150SRM hydrochloride) is a selective, CNS penetrant, and orally active inhibitor of p38α MAPK with a Ki of 101 nM. 了解更多 -
MW-150 dihydrochloride dihydrate
Catalog No. A21860 p38α MAPK inhibitorMW-150 dihydrochloride dihydrate (MW01-18-150SRM dihydrochloride dihydrate) is a selective, CNS penetrant, and orally active inhibitor of p38α MAPK with a Ki of 101 nM. 了解更多 -
BMS-582949 hydrochloride
Catalog No. A21914 p38α MAPK inhibitorBMS-582949 hydrochloride is an orally active and highly selective p38α MAPK inhibitor, with an IC50 of 13 nM. 了解更多 -
Ralimetinib
Catalog No. A21942 p38 MAPK α/β inhibitorRalimetinib (LY2228820) is a potent and selective, ATP-competitive inhibitor of p38 MAPK α/β, with IC50s of 5.3 and 3.2 nM, respectively. 了解更多 -
p38-α MAPK-IN-1
Catalog No. A21036 MAPK14 inhibitorp38-α MAPK-IN-1 is an inhibitor of MAPK14 (p38-α), with IC50 of 2300 nM in EFC displacement assay, and 5500 nM in HTRF assay. 了解更多 -
MAPK13-IN-1
Catalog No. A21038 MAPK13 (p38??) inhibitorMPAK13-IN-1 is a MAPK13 (p38δ) inhibitor, with an IC50 of 620 nM. 了解更多 -
CMPD-1
Catalog No. A16040 -
LY2228820 (Ralimetinib)
Catalog No. A10545 -
VX-745
Catalog No. A10983 -
Pamapimod (R-1503)
Catalog No. A13551 -
Losmapimod (GW856553X)
Catalog No. A12526 p38 MAPK 抑制剂Losmapimod,也称为GW856553或GW856553X,是葛兰素史克(GlaxoSmithKline)开发的药物,可作为酶家族的选择性抑制剂,称为p38促分裂原活化蛋白激酶,其作用于p38α和p38β的pKi分别为8.1和7.6 。 了解更多 -
Talmapimod (SCIO-469)
Catalog No. A12770